InvestorsObserver
×
News Home

Is Summit Therapeutics Inc (SMMT) Stock Worth a Buy Tuesday?

Tuesday, October 17, 2023 10:42 AM | InvestorsObserver Analysts

Mentioned in this article

Is Summit Therapeutics Inc (SMMT) Stock Worth a Buy Tuesday?

Summit Therapeutics Inc (SMMT) stock is higher by 60.48% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives SMMT stock a score of 33 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 47. SMMT's rank also includes a short-term technical score of 51.
Overall Score - 33
SMMT has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on SMMT!

What's Happening with SMMT Stock Today

Summit Therapeutics Inc (SMMT) stock has gained 13.71% while the S&P 500 has fallen -0.17% as of 10:31 AM on Tuesday, Oct 17. SMMT is higher by $0.24 from the previous closing price of $1.75 on volume of 1,205,650 shares. Over the past year the S&P 500 has gained 18.72% while SMMT is higher by 60.48%. SMMT lost -$1.70 per share in the over the last 12 months. Click Here to get the full Stock Report for Summit Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App